Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
19.91
+0.54 (2.79%)
At close: Jul 17, 2026, 4:00 PM EDT
19.92
+0.01 (0.05%)
After-hours: Jul 17, 2026, 6:38 PM EDT
Relay Therapeutics Stock Forecast
Stock Price Forecast
According to 13 analysts polled by S&P Global, Relay Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $25.08. The average 1-year stock price forecast is 25.97% higher than the current stock price, while the lowest is $20 (+0.45%) and the highest is $32 (+60.72%).
Price Target: $25.08 (+25.97%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Relay Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 10 | 10 | 11 | 10 | 10 |
| Buy | 2 | 2 | 2 | 2 | 2 | 3 |
| Hold | 0 | 0 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 13 | 13 | 12 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Initiates $29 | Buy | Initiates | $29 | +45.66% | Jul 16, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Initiates $28 | Buy | Initiates | $28 | +40.63% | Jul 8, 2026 |
| TD Cowen | TD Cowen | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 18, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $13 → $22 | Buy | Maintains | $13 → $22 | +10.50% | Jun 3, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $21 | Buy | Maintains | $21 | +5.47% | Jun 3, 2026 |
Financial Forecast
Revenue This Year
12.54M
from 15.36M
Decreased by -18.34%
Revenue Next Year
15.95M
from 12.54M
Increased by 27.22%
EPS This Year
-1.53
from -1.61
EPS Next Year
-1.65
from -1.53
EPS and Forward PE are based on non-GAAP adjusted numbers.